Middle East Pharmaceutical Industries Co. (4016.SR)
SAR 120.2
(-0.5%)
SAR 120.2
(-0.5%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.29 SAR | 10.77% |
| 2022 | 2.97 SAR | -10.27% |
| 2021 | 3.31 SAR | -9.07% |
| 2020 | 3.64 SAR | 34.81% |
| 2019 | 2.70 SAR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 1.09 SAR | 131.91% |
| 2024 Q1 | 0.47 SAR | -61.16% |
| 2023 Q4 | 1.21 SAR | 0.0% |
| 2023 Q3 | 1.21 SAR | 34.44% |
| 2023 FY | - SAR | 10.77% |
| 2023 Q2 | 0.90 SAR | 3729.03% |
| 2023 Q1 | -0.02 SAR | -102.38% |
| 2022 Q1 | 0.44 SAR | 0.0% |
| 2022 FY | - SAR | -10.27% |
| 2022 Q4 | 1.04 SAR | 0.0% |
| 2022 Q2 | 1.01 SAR | 129.55% |
| 2022 Q3 | 1.04 SAR | 2.97% |
| 2021 FY | - SAR | -9.07% |
| 2020 FY | - SAR | 34.81% |
| 2019 FY | - SAR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Al-Dawaa Medical Services Company | 3.87 SAR | 14.987% |
| Nahdi Medical Company | 6.87 SAR | 52.111% |
| Al-Razi Medical Co. | 0.45 SAR | -631.111% |
| Almujtama Alraida Medical Co. | 1.20 SAR | -174.167% |